Abstract

Tracking drug disposition in the skin in a non-destructive and at least semi-quantitative fashion is a relevant objective for the assessment of local (cutaneous) bioavailability. Confocal Raman spectroscopy has been shown potentially useful in this regard and, importantly, recent advances have enabled the presence of applied chemicals in the viable epidermis below the stratum corneum (SC) to be determined without ambiguity and having addressed the challenges of (a) background signals from endogenous species and noise and (b) signal attenuation due to absorption and scattering. This study aimed to confirm these observations using a different vibrational spectroscopy approach - specifically, stimulated Raman scattering (SRS) microscopy – and the more conventional in vitro skin penetration test (IVPT). SRS is a nonlinear optical imaging technique which enables more precise location of the skin surface and enhanced skin depth resolution relative to confocal Raman microscopy. The method can also probe larger areas of the sample under investigation and identify the localization of the permeating chemical in specific structural components of the skin. Here, SRS was shown capable of tracking the uptake and distribution of 4-cyanophenol (CP), the same model compound used in the recent confocal Raman investigation, at depths beyond the SC following skin treatment with different vehicles and for different times. The SRS results correlated well with those from the confocal Raman experiments, and both were consistent with independent IVPT measurements. Acquired images clearly delineated CP preference for the intercellular lipid layers of the SC relative to the corneocytes. The stage is now set to apply these and other
correlative techniques to examine commercial drug products.
Original languageEnglish
Pages (from-to)797-807
Number of pages11
JournalJournal of Controlled Release
Volume368
Early online date22 Mar 2024
DOIs
Publication statusPublished - 30 Apr 2024

Data Availability Statement

Data will be made available on request.

Funding

This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (1-U01-FD 006533) totalling $1.25 M with 100% funded by FDA]/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government. Valuable insight from and stimulating discussions with Drs. Priyanka Ghosh, Sam Raney and Markham Luke from the FDA's Office of Generic Drugs, and from Professor Jane White at the University of Bath, are gratefully acknowledged. NAB thanks the Community for Analytical Measurement Science for a 2020 CAMS Fellowship Award funded by the Analytical Chemistry Trust Fund.

FundersFunder number
U.S Food and Drug Administration1-U01-FD 006533

    Keywords

    • Raman spectroscopy
    • Stimulated Raman scattering microscopy
    • In vitro permeation test
    • Cutaneous pharmacokinetics
    • Drug disposition in skin

    Fingerprint

    Dive into the research topics of 'Evaluation of chemical disposition in skin by stimulated Raman scattering microscopy'. Together they form a unique fingerprint.

    Cite this